|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,045 INR | +1.83% |
|
+1.43% | +35.14% |
NEW DELHI (Reuters) - The Indian government hailed as "historic" a Supreme Court ruling on Monday against a plea by Swiss drugmaker Novartis AG to protect the patent on its drug Glivec.
Commerce and Industry Minister Anand Sharma said the ruling -- seen as a victory by health rights campaigners -- reaffirmed provisions in Indian law that mandate the need for substantial innovation before new patents are issued on medicines.
(Reporting By Matthias Williams; Writing by Frank Jack Daniel, editing by Ross Colvin)
| 1st Jan change | Capi. | |
|---|---|---|
| +35.14% | 304M | |
| +25.61% | 660B | |
| +23.05% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +12.60% | 219B | |
| -9.78% | 196B | |
| +6.78% | 199B | |
| -8.75% | 149B |
NOVARTIS INDIA LIMITED 
By 
